College of Pharmacy

Chakraborty Lab

Led by Anutosh Chakraborty · Cellular and Systems Pharmacology

Auto-generated from UF undergraduate research symposium abstracts

What we study

This lab studies the molecular causes of obesity and fatty liver disease, including the enzyme IP6K1 and the ligase Ube4A, and develops inhibitors as possible treatments.

What working here is like

  • Wet lab
  • Mice
  • Cells in a dish
  • No coding
Projects
2

Current projects

Ube4A in NAFLD/NASH

NIH project on how Ube4A regulates liver disease in hepatocytes.

IP6K1 inhibitors

Developing inhibitors for fatty liver disease.

Summaries are written by AI in plain language from public symposium abstracts and may be imperfect.

How to reach out

Anutosh Chakraborty hasn't set up this page yet. You can also look them up in the UF directory (search “Anutosh Chakraborty”).

Log in to save this lab, see how to contact the PI, and write your outreach email.

Are you in this lab?Claim this lab

Open positions

No positions posted right now. Many labs still take undergrads who reach out to them, so see how to get in touch.
Chakraborty Lab · Anutosh Chakraborty | JoinLattice